Doutora em Ciências Biológicas (Biologia Celular) pela UEM/PR, Universidade Estadual de Maringá, Docente Adjunto da Universidade Estadual de Maringá, Maringá (PR), Brasil
Auto-generated profile, based on publicly available information
Vilma Aparecida Ferreira de Godoi
Doutora em Ciências Biológicas (Biologia Celular) pela UEM/PR, Universidade Estadual de Maringá, Docente Adjunto da Universidade Estadual de Maringá, Maringá (PR), Brasil
Photodynamic therapy (PDT) promotes cell death, and it has been successfully employed as a treatment resource for neuropathic complications of diabetes mellitus (T1DM) and hepatocellular carcinoma. The liver is the major organ involved in the regulation of energy homeostasis, and in pathological conditions such as T1DM, changes in liver metabolic pathways result in hyperglycemia, which is associated with multiple organic dysfunctions. In this context, it has been suggested that chlorophyll-a and its derivatives have anti-diabetic actions, such as reducing hyperglycemia, hyperinsulinemia, and hypertriglyceridemia, but these effects have not yet been proven. Thus, the biological action of PDT with chlorophyll-a on hepatic parameters related to energy metabolism and oxidative stress in T1DM Wistar rats was investigated. Evaluation of the acute effects of this pigment was performed by incubation of isolated hepatocytes with chlorophyll-a and the chronic effects were evaluated by oral treatment with chlorophyll-based extract, with post-analysis of the intact liver by in situ perfusion. In both experimental protocols, chlorophyll-a decreased hepatic glucose release and glycogenolysis rate and stimulated the glycolytic pathway in DM/PDT. In addition, there was a reduction in hepatic oxidative stress, noticeable by decreased lipoperoxidation, reactive oxygen species, and carbonylated proteins in livers of chlorophyll-treated T1DM rats. These are indicators of the potential capacity of chlorophyll-a in improving the status of the diabetic liver.
28 November 2022 in Journal of Drug Delivery Science and Technology
Context: Caloric restriction (CR) is suggested for overweight control. Objective: Systemic and liver glucose metabolism in the reduced-litter (RL) rat model under 30% CR was investigated. Materials and methods: Newborn litters were organised in control (G9); RL with free diet (G3L); and RL with CR (G3R). Assessments were made at the age of 90 d. Results: Higher liver glycogen content and changes in systemic glucose handling were found in the RL groups. Hepatocyte glucose metabolism was similar in groups G9 and G3L, but basal glucose production and glycogenolysis were higher, while gluconeogenesis and basal glycolysis were lower in the G3R. Urea production was lower in the RL groups. Discussion: The altered glucose handling of the RL adult rats was not reversed by moderate (30%) CR. Hepatocyte glucose and nitrogen metabolism were changed by both early overfeeding and current feeding conditions. Conclusions: RL and CR alter systemic and liver glucose metabolism.
1 January 2019 in Brazilian Journal of Medical and Biological Research
Photodynamic therapy, by reducing pain and inflammation and promoting the proliferation of healthy cells, can be used to treat recurrent lesions, such as diabetic foot ulcers. Studies using the photosensitizer phthalocyanine, together with the nanostructured copolymeric matrix of Pluronic® and Carbopol® for the treatment of diabetic foot ulcers and leishmaniosis lesions, are showing promising outcomes. Despite their topical or subcutaneous administration, these molecules are absorbed and their systemic effects are unknown. Therefore, we investigated the effect of the subcutaneous administration of the hydroxy-aluminum phthalocyanine hydrogel without illumination on systemic parameters, markers of liver injury, and liver energy metabolism in type 1 diabetic Swiss mice. Both the hydrogel and the different doses of phthalocyanine changed the levels of injury markers and the liver glucose release, sometimes aggravating the alterations caused by the diabetic condition itself. However, the dose of 2.23 µg/mL caused less marked plasmatic and metabolic changes and did not change glucose tolerance or insulin sensitivity of the diabetic mice. These results are indicative that the use of hydroxy-aluminum phthalocyanine hydrogel for the treatment of cutaneous ulcers in diabetic patients is systemically safe.
2 August 2022 in Varia Scientia - Ciências da Saúde
Objetivo: Objetivou-se neste estudo, analisar se a ação combinada da L-glutamina e insulinoterapia melhora os parâmetros morfoquantitativos dos ácinos da parótida de ratos diabéticos. Métodos: Vinte e cinco ratos foram distribuídos em cinco grupos: Normoglicêmico (CSS); diabético (DSS); diabético suplementado com L-GLN (D-GLN-S); diabético e com injeção subcutânea de insulina Tresiba® (D-S-TRE) e diabético suplementado com L-GLN e com injeção subcutânea de insulina Tresiba® (D-GLN-TRE). Durante 30 dias, houve suplementação diária com solução salina e/ou L-glutamina (400 mg/kg por gavagem), e injeção subcutânea de solução salina e/ou Insulina Tresiba® (5 U/kg). Resultados: Não houve diferença significativa na densidade acinar dos grupos diabéticos em relação ao grupo controle CSS. Porém, o grupo tratado com apenas com insulina (D-S-TRE) e insulina mais a L-GLN (D-GLN-TRE) mostraram menor densidade acinar quando comprados com o grupo diabético DSS. Todos os grupos diabéticos apresentaram menor área acinar média em relação ao grupo controle CSS. Entre os grupos diabéticos, a área acinar média do grupo D-GLN-TRE foi maior comparada aos grupos DSS, D-GLN-S e D-S-TRE. Conclusão: Estes dados apontam para o efeito protetor da L-glutamina combinada com a insulina ao prevenir a densidade e atrofia acinar da glândula parótida de ratos diabéticos.
Polymeric micelles in oxyalkylic blocks has been investigated as carriers of hydrophobic photosensitizers for intravenous administration in photodynamic therapy. This study evaluated the uptake of hypericin carried by polymeric micelles formed with Pluronics ® P123, F127 and P84 and their photoinduced actions on gluconeogenesis in perfused livers of mice. Uptake and photoinduced action of F127-carried hypericin were also evaluated against cultured human hepatoblastoma HepG2 cells. Respiratory activity was assessed in isolated hepatic mitochondria. Hypericin is also investigated as a promising photosensitizer and it was herein photoinduced with red light. This procedure should activate this agent to a lower extension and prevent damage against healthy tissues. Hypericin carried by P123, P84 and F127 micelles was substantially taken up by perfused livers. However, P123 and P84 inhibited hepatic gluconeogenesis by impairing the aerobic energy supply of the cell, effects probably associated with their more hydrophobic character. Hypericin carried by F127, a more hydrophilic micelle, did not inhibit gluconeogenesis and did not modify the mitochondrial respiration at concentrations lower than 2 µM in the dark or when photoinduced with red light. What is more, F127-carried hypericin was substantially taken up by HepG2 cells and, when photoinduced with red light, considerably decreased the viability of these cells. The results show that F127-carried hypericin could be a suitable photosensitizer system to be used in photodynamic therapy against liver tumors, especially if it is photoinduced with red light, which should activate the molecule to a lower extension and prevent damage to the healthy tissue.